TechnoDerma Medicines
Latest round
- Series A
Last raised
- Jan 2023
Total raised
- Undisclosed
Investors
- 5
About TechnoDerma Medicines
Based in Jiaxing, China, and established in 2014, TechnoDerma Medicines Inc. previously known as Tekeluo Biology is a biotechnology company that engages in the research and development of small-molecule drugs for skin diseases. It has established partnerships with Precedo, Pharmaron, and so on.D. from Washington State University in the United States and worked in pharmaceutical corporations such as OSI Pharmaceutical, Pfizer, and AstraZeneca. In December 2023, the company completed Phase 1 Dose Escalation Clinical Trial of TDM-180935 for Atopic Dermatitis.'s R&D pipeline includes candidate drugs for hair loss, atopic dermatitis, psoriasis, and systemic lupus erythematosus (SLE). The company's candidate drug, TDM-105795, for the treatment of androgenetic alopecia(AGA), has been granted global intellectual property rights. The company is in R&D on a candidate drug for psoriasis and atopic dermatitis, which has entered the Chemistry and Manufacturing Controls (CMC) and preclinical stage. The atopic dermatitis program passed an Investigational new drug (IND) certification in July 2022 and is in phase I clinical trials. The company will use the pre-series B funds for the clinical development of hair projects and China-US IIa clinical trials of eczema and dermatitis projects.
Who invested in TechnoDerma Medicines
5 investors across 2 rounds
See all investors in TechnoDerma Medicines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TechnoDerma Medicines
Who invested in TechnoDerma Medicines?
TechnoDerma Medicines has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TechnoDerma Medicines raised?
TechnoDerma Medicines has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did TechnoDerma Medicines last raise money?
TechnoDerma Medicines's most recent round on record is a Series A, in Jan 2023.
What does TechnoDerma Medicines do?
Based in Jiaxing, China, and established in 2014, TechnoDerma Medicines Inc.
Where is TechnoDerma Medicines headquartered?
TechnoDerma Medicines is headquartered in Chengdu, China.
Which VCs invest in companies like TechnoDerma Medicines?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at TechnoDerma Medicines's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like TechnoDerma Medicines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.